Drug Trial Radar · NCT06693648
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
549
Actual
Start
Feb 18, 2025
Primary completion
Dec 22, 2025
Study completion Apr 13, 2026
Sponsor
- Lead sponsor
- AmzellIndustry
- Sponsor type
- Industry
- Collaborators
- NBCD A/S
- First posted
- Nov 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, 6-week trial of a formulation of AMZ001 once daily versus placebo once daily.
Conditions
- Osteoarthritis of Knee
- Osteoarthritis, Knee
Interventions
AMZ001 Diclofenac gelDrug
Diclofenac gel applied once daily
Placebo gelDrug
Matching placebo gel applied once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the WOMAC Pain Sub-score in the Target Knee at Week 2.Time frame: Baseline and Week 2
Locations
11 sites in 5 countries. Site status is shown where the registry gives one.
Millennium Clinical Trials
Thousand Oaks, California
Eastern Research Inc
Hialeah, Florida
Future Medical Research
Longwood, Florida
DelRicht Research
New Orleans, Louisiana
DelRicht Research
Rockville, Maryland
Oakland Medical Research
Troy, Michigan
West Clinical Research
Morehead City, North Carolina
hong Kong Center for Clinical Research
Hong Kong, China
Charles University
Prague, Czechia
Sanos Clinic
Herlev, Denmark
Medyczne Centrum Hetmanska Piotr Leszczynski
Poznan, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.